Glonghui September 10 | CCB International maintained Kangfang Biotech's “outperforming the market” rating, and the target price was raised to HK$59.
建银国际：将康方生物目标价上调至59港元
CICC International: Raises target price for Akeso to HK$59.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated